Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.

@article{Obrien2007ProgesteroneVG,
  title={Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.},
  author={John M O'brien and C David Adair and David F.V. Lewis and David William Reid Hall and Emily A. DeFranco and Shalini S. Fusey and Priya Soma-Pillay and KendrickA. Porter and Helen How and R C Schackis and Daniel Eller and Yash Trivedi and George Vanburen and Meena Rani Khandelwal and K Trofatter and D Vidyadhari and Jaya Vijayaraghavan and Jennifer W. Weeks and Bonnie J. Dattel and Evan Newton and Cynthia Chazotte and Germ{\'a}n Urz{\'u}a Valenzuela and Pavel Calda and Mohammad Bsharat and George W. Creasy},
  journal={Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology},
  year={2007},
  volume={30 5},
  pages={
          687-96
        }
}
OBJECTIVE Preterm birth is the leading cause of perinatal morbidity and mortality worldwide. Treatment of preterm labor with tocolysis has not been successful in improving infant outcome. The administration of progesterone and related compounds has been proposed as a strategy to prevent preterm birth. The objective of this trial was to determine whether prophylactic administration of vaginal progesterone reduces the risk of preterm birth in women with a history of spontaneous preterm birth… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 104 CITATIONS

FILTER CITATIONS BY YEAR

2007
2018

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 11 Citations per year over the last 3 years

Similar Papers

Loading similar papers…